Allianz

Key Findings

• Economic: Allianz Trade and Harel are equal shareholders in ICIC, an Israeli credit insurer reporting approximately 500 policyholders and annual insured sales exceeding USD 15 billion. These are ICIC-wide operating figures, not Allianz revenue or attributable profits.¹
• Economic: Published research attributes approximately USD 2.67 billion in Israeli government bonds to vehicles managed by Allianz-group asset managers in September 2025. The aggregate is a historical research finding; ultimate beneficial ownership, proprietary Allianz ownership and exact October 2026 balances remain unverified.²
• Military: Allianz formerly provided employers’ liability insurance benefiting Elbit Systems UK. The identified policy was reported replaced by Aspen in December 2025; other possible insurance arrangements remain unresolved, and reported defence-company securities exposure requires separate verification.^{3, 4, 5}
• Not found: No public evidence identified of direct Allianz weapons manufacture, Israeli military procurement contracts, military targeting software or Project Nimbus participation. The documented relationships concern insurance, investment and civilian technology services.^{3, 6, 7, 8}

Target Profile

Executive Summary

Allianz’s documented Israel/Palestine nexus is principally financial and commercial. Its clearest local operating relationship is Allianz Trade’s equal ownership of the Israeli Credit Insurance Company, ICIC, alongside Harel. Euler Hermes acquired an initial 33% interest in 2007 and increased it to 50% during the second quarter of 2013. ICIC’s subsequently published corporate description continues to identify equal ownership and describes domestic and international trade-credit insurance, guarantees and annual insured sales exceeding USD 15 billion. The evidence establishes substantial commercial transaction coverage through an Israeli operating venture, while leaving Allianz-attributable premiums, profits, taxes and dividends unquantified.^{1, 15}

A second significant channel is investment management. PIMCO’s historical portfolio schedules identify Israeli sovereign and corporate debt, while research attributed to Profundo reports approximately USD 2.67 billion in Israeli sovereign bonds across Allianz-group managed fund vehicles in September 2025. Reporting also supports continuing substantial exposure in early 2026, but does not provide a complete, independently reconciled entity-by-entity inventory. These findings establish managed investment exposure; they do not establish that Allianz SE purchased every security with shareholder capital or that the reported September 2025 total remained outstanding in October 2026.^{2, 16, 17}

The defence-related record comprises a former insurance relationship and reported securities holdings. Allianz provided employers’ liability insurance benefiting Elbit Systems UK, with replacement by Aspen reported in December 2025. Campaign research separately attributes investments in Elbit and other defence-related companies to Allianz. The identified policy’s cessation is material mitigation; it does not establish that all possible insurance or investment relationships ended. Conversely, Elbit’s weapons manufacturing and Israeli procurement contracts cannot be attributed to Allianz as its own manufacturing or procurement activity.^{3, 4, 5, 18}

The political record includes Allianz’s participation in an October 2023 collective German corporate statement condemning Hamas’s attacks, acknowledging civilian suffering in Israel and Gaza, opposing antisemitism and supporting Jewish communities in Germany. It does not establish endorsement of particular Israeli military operations or settlement policies. Allianz Ireland disputes allegations of complicity, invokes legal and fiduciary obligations, and denies direct Israeli sovereign-bond holdings by the Irish entity. No public evidence identified of direct Allianz military donations, settlement-specific operations, offensive cyber supply or Israeli military digital contracts. The fixed, human-vetted V6.6 result is BRS 542, Tier C (Substantial Complicity), driven by the economic domain.^{6, 7, 19, 20, 21, 22}

Timeline of Relevant Events

Corporate Overview

Allianz SE is the Munich-based German holding company of an international insurance and asset-management group. Relevant businesses identified in the audits include Allianz Trade/Euler Hermes, Allianz X GmbH, Allianz Re, PIMCO, Allianz Global Investors, Allianz Partners and UK insurance operations. Their activities require separate attribution: investment management, reinsurance, venture investment and insurance underwriting are distinct channels.^{3, 9, 25, 30}

ICIC is the principal identified Israeli operating-company investment. Its equal shareholders are Allianz Trade and Harel; an industry-association description independently corroborates the 50/50 structure and ICIC’s use of Euler Hermes systems and international connections. The evidence establishes an operationally integrated commercial venture, without establishing unilateral Allianz control. The 2013 registration document accounted for ICIC using the equity method; the current accounting treatment and governing shareholder agreement were not established.^{1, 15, 31}

Allianz X’s technology portfolio includes Fundbox, while Lemonade and NEXT Insurance are classified as exited investments. NEXT’s subsequent ownership belongs to Munich Re/ERGO, a separate corporate group. Allianz Re’s separately announced multiyear NEXT reinsurance commitment cannot be presumed terminated solely because Allianz X exited its equity position.^{14, 24, 25, 27, 30}

The Irish insurer Allianz p.l.c. is the contractual GAA sponsor. The GAA review expressly distinguished that entity from affiliates implicated in investment and underwriting findings. Likewise, an Allianz board member’s role at Sygnia does not establish Sygnia as an Allianz subsidiary or establish an Allianz military-technology contract.^{21, 32}

Domain Summaries

Military: Military

Mechanism of Involvement

The established historical service was employers’ liability insurance benefiting Elbit Systems UK. Public evidence documents the relationship during 2024–2025, followed by reported replacement in December 2025. The precise underwriting legal entity, original commencement date, premium, policy number and coverage limits remain unestablished. The retrieved record does not identify a particular weapons system or Israeli military installation as an insured asset.^{3, 4}

Investment research supplies a separate financial channel. The March 2025 investigation attributed approximately USD 452 million across 15 defence-related companies to Allianz at a February 2025 reference point. An August 2026 campaign table attributed USD 1,721,308 in Elbit equity exposure and positions in Lockheed Martin, Boeing, BAE Systems, General Dynamics, Leonardo, Rheinmetall, Rolls-Royce and L3Harris. Fund-level identities, beneficial ownership and continuation after the observation date remain unverified.^{5, 18}

Elbit’s own military supply is documented independently. Its SEC-filed May 2024 announcement concerned approximately USD 760 million in ammunition contracts with Israel’s Ministry of Defence. That establishes Elbit’s procurement relationship; Allianz is not identified as a contracting participant.³³

Counter-Arguments and Evidence Limits

The strongest mitigation is the reported cessation of the specifically identified insurance policy. Current underwriting cannot be inferred from historical coverage, although AFSC leaves other possible arrangements unresolved. Securities holdings also do not establish manufacture, component supply or participation in an investee’s particular weapons programme.^{3, 4, 5}

No public evidence identified of direct Allianz procurement contracts with the Israeli military or security bodies; weapons manufacture; military co-development; military logistics; construction or demolition contracts; or purpose-built targeting software. No public evidence identified of a judicial decision finding Allianz liable for supplying prohibited weapons to Israel. Allianz’s published restrictions cover specified controversial-weapons categories, although they do not constitute a universal exclusion of conventional defence manufacturers.^{3, 8}

These distinctions preserve the fixed Military score of 0.00 without erasing the historical insurance and reported investment record.

Named Entities and Evidence Map

Digital: Digital

Mechanism of Involvement

The documented technology relationships are civilian insurance and investment activities. The 2019 Microsoft agreement envisaged moving core Allianz Business System components to Azure, with Syncier providing an insurance platform. The 2021 Google Cloud collaboration combined customer-authorised security assessments with commercial cyber insurance. Neither announcement identifies an Israeli military or intelligence customer.^{6, 7}

Allianz X’s investment in Fundbox provides an Israeli-founded technology connection. Fundbox’s portfolio description concerns machine-learning-based business credit and transaction analysis, and its own website lists Allianz as an investor. The evidence does not establish Allianz operation of Fundbox’s Israeli engineering facilities or a military or surveillance application.^{14, 34, 35}

Lemonade and NEXT are historical investments classified as exited. Coalition and SandboxAQ document broader cybersecurity and AI portfolio interests, without establishing supply of those technologies to Israeli state institutions.^{23, 24, 36, 37}

Counter-Arguments and Evidence Limits

No public evidence identified of Allianz providing Israeli military targeting AI, offensive cyber tools, biometric surveillance or autonomous weapons software. No public evidence identified of Allianz participation in Project Nimbus. Relationships with Microsoft or Google Cloud cannot establish participation in a separate Israeli government contract.^{6, 7, 36, 37}

Group privacy disclosures document international transfers and safeguards, but do not establish Israeli hosting, processors or jurisdictional routing. No public evidence identified of an Allianz-owned Israeli data centre or research laboratory. The available disclosures do not provide comprehensive tenant-level routes or country-by-country recipient registers, so an Israel-specific data-exposure determination remains unsupported.^{30, 38}

Investment is also distinct from internal procurement: portfolio membership does not prove Allianz deploys an investee’s products. Historical cloud announcements do not establish current contractual status or deployment completion. These limits support the fixed Digital score of 0.00.^{6, 7, 24}

Named Entities and Evidence Map

Economic: Economic

Mechanism of Involvement

ICIC supplies the strongest directly documented local operating mechanism. Its 50/50 Allianz Trade–Harel ownership is supported by corporate and industry-association sources. ICIC reports approximately 500 policyholders, annual insured sales exceeding USD 15 billion and trade involving 140 countries. Its product descriptions cover domestic business credit, international transactions and guarantees; they also identify Allianz Trade credit-risk information as an operational input.^{1, 15, 31, 39, 40}

These figures measure ICIC’s supported commercial transactions. They are neither Allianz revenue nor capital transferred to Israel. The reviewed evidence does not quantify Allianz’s share of premiums, dividends, Israeli taxes or net earnings, and does not identify individual settlement-related customers.^{1, 15}

Sovereign debt supplies a second substantial channel. Profundo-based reporting attributes approximately USD 2.67 billion in Israeli government bonds to Allianz-group managed fund vehicles in September 2025, encompassing German operations, PIMCO platforms and Allianz Global Investors. The same investigation reports approximately USD 32 million in November 2024 and continuing substantial exposure in early 2026. Its March 2026 figure of approximately USD 2.43 billion is country-attributed, rather than a separately verified Allianz consolidated total.²

Follow the Money separately reported approximately USD 960 million in PIMCO-attributed Israeli sovereign-bond purchases. That figure concerns a different research scope or observation period and must not be added to the USD 2.67 billion aggregate. The larger aggregation also excludes separately discussed external institutional-client mandates.^{2, 41}

Historical fund-level evidence adds specificity. At 31 March 2025, PIMCO’s Global Bond Opportunities Portfolio (Unhedged) reported four Israeli sovereign positions worth USD 1.291 million. Its Emerging Markets Bond Portfolio separately reported USD 1.102 million in Israeli sovereign debt and USD 671,000 in ICL Group, Israel Electric Corporation and Leviathan Bond corporate debt. These are portfolio holdings at a historical date. The audit recovered them from indexed schedules; the live endpoints subsequently served March 2026 editions, limiting reproducibility without retained historical copies.^{16, 17}

Defence-company securities, the former Elbit insurance policy and venture investments constitute additional economic relationships. Allianz X’s exact contribution to NEXT’s USD 265 million financing round was undisclosed. Its NEXT ownership subsequently ended; Fundbox remained publicly represented in the reviewed portfolio. Empathy appears as an investment lead, with ownership percentage, control and final exit status unresolved.^{3, 5, 14, 24, 25, 27, 42}

Counter-Arguments and Evidence Limits

Allianz’s strongest defence is the distinction between managed assets and proprietary ownership. Fund holdings may benefit external investors; their aggregate cannot automatically be treated as Allianz SE shareholder-funded assets, direct corporate returns or donations. Exact October 2026 balances, beneficial investors and acquisition histories remain unverified. No public evidence identified of Allianz or PIMCO acting as named lead underwriter or retail distributor for a specific Israeli sovereign issue.^{2, 41, 3}

ICIC is an equal-shareholder civilian insurer, with unilateral Allianz control unestablished. No public evidence identified of a named settlement customer, settlement-located Allianz operation, settlement construction financing or quantified settlement-derived revenues. No public evidence identified of direct agricultural sourcing or settlement-product importation. NEXT’s exit and Elbit policy cessation must mitigate current attribution.^{1, 15, 3, 27}

Allianz has stated that its investment decisions comply with applicable law and ESG standards, while declining to discuss individual investments. That response is part of the evidence record; it does not independently reconcile the reported holdings.⁴¹

Named Entities and Evidence Map

Political: Political

Mechanism of Involvement

Allianz’s confirmed October 2023 collective endorsement condemned Hamas’s attacks, acknowledged suffering among Israeli and Gaza civilians, opposed antisemitism and invoked Germany’s historical responsibility. The evidence does not establish approval of specific Israeli government policies, military operations or settlement expansion, or identify the authorising Allianz executive.¹⁹

Allianz Ireland’s August 2026 response rejected allegations of complicity and disputed the methodology and conclusions of the UN Special Rapporteur’s report. It argued that sovereign-market restrictions belong to governments, international institutions and courts, while invoking sanctions compliance and fiduciary obligations.²⁰

Public controversy also involved GAA sponsorship and protest litigation. The GAA’s December 2025 review distinguished Irish sponsor Allianz p.l.c. from relevant affiliates and recommended retaining the partnership. April 2026 reporting described civil claims for approximately GBP 300,000 against six alleged protest participants; final disposition remained unestablished.^{21, 28, 29}

Counter-Arguments and Evidence Limits

The strongest entity-specific defence is Allianz Ireland’s statement that it holds no Israeli government bonds, does not invest Irish customer premiums in them, and has no direct Elbit relationship. The GAA review did not attribute affiliate bond purchases to the Irish sponsor. These findings do not negate group-level investment evidence, but prevent its indiscriminate attribution to every subsidiary.^{21, 22}

Allianz Ireland also stated that it had supported Irish Red Cross assistance for affected civilians. No public evidence identified independently establishing the contribution’s amount, delivery, timing or continuing status. Irish Red Cross publications document Palestinian humanitarian assistance without identifying Allianz as the funder of particular services or expenditures.^{22, 43, 44}

No public evidence identified of qualifying anti-BDS lobbying expenditure, direct military or settlement donations, executive settlement advocacy, Palestine-related employee discipline or sponsorship of Israeli military ceremonies. Litigation over alleged property damage does not establish employee suppression. No specific settlement operation was established for dual attribution to economic and political activity.^{20, 21, 22, 29}

Named Entities and Evidence Map

Complicity Index Score

Method: V6.6. Final human-vetted values; reproduced unchanged.

• V_MAX: 6.50 Avg_OTHERS: 0.00
• BRS Score: 542 Tier: C (Substantial Complicity)

The economic domain drives V_MAX through the documented ICIC ownership and operating relationship, managed Israeli sovereign-debt exposure and additional insurance and investment channels, subject to the attribution and temporal limits above.^{1, 15, 2, 3} The fixed political Impact value of 2.00 coexists with zero Magnitude, Proximity and domain score; no separate numerical derivation was supplied, and none is inferred. The resulting BRS 542/Tier C classification uses the scale-free, evidence-only, human-vetted method; it is a corpus classification rather than a judicial finding.

Methodology Note

• This dossier compiles only the four supplied domain audits. Corporate disclosures, portfolio schedules, reporting and campaign findings retain their respective evidentiary status; repetition of one investigation is not treated as independent reconstruction.
• Under the supplied scale-free framework, Impact (I) describes activity type, Magnitude (M) describes scale and Proximity (P) describes directness. All final scores are fixed.
• Temporal attribution distinguishes current, historical and unresolved relationships. Exited investments and terminated policies mitigate present involvement; an equity exit does not automatically terminate a separate reinsurance contract.^{3, 24, 25, 27}
• Entity attribution prohibits transitive guilt: investee conduct, external-client assets, affiliate activity and personal executive conduct require separate evidence. Managed securities are not automatically proprietary Allianz assets.^{2, 21}
• An established settlement operation would dual-count under Economic and Political. No specific Allianz settlement operation or named settlement-insurance customer was established in the supplied record.^{1, 21}
• “No public evidence identified” records a negative finding within the examined material, not proof of universal absence. Unverified ownership, current balances, policy scope and humanitarian contributions remain qualified.